Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Opin Pharmacol. 2012 Oct;12(5):569-75. doi: 10.1016/j.coph.2012.07.016. Epub 2012 Aug 15.

PET imaging: implications for the future of therapy monitoring with PET/CT in oncology.

Author information

  • 1Comprehensive Cancer Imaging Center, Imperial College, Hammersmith Hospital London, UK.

Abstract

Among the methods based on molecular imaging, the measure of the tracer uptake variation between a baseline and follow-up scan with the SUV and [(18)F]FDG-PET/CT is a very powerful tool for assessing response to treatment in oncology. However, the development of new targeted therapeutics and tissue pharmacokinetic evaluation of existing ones are increasingly requiring therapy monitoring with alternative tracers and indicators. In parallel, the potential predictive and prognostic value of other image-derived parameters, such as tumour volume and textural features, relating to tumoral heterogeneity, has recently emerged from several works.

Copyright © 2012 Elsevier Ltd. All rights reserved.

PMID:
22901680
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk